RE: CASH BURN6 Sep 2024 10:57
I agree doubtful to get any traction in terms of sales. But I think the trade is there based on market cap, and they have still got a cash runway. There are pharmas with a lot bigger market caps making piddly amounts of revenue. It’s what happens to small cap pharmas, they suck up money and don’t amount to anything (same as small cap explorers). But there are opportunities to trade. Let’s see, trade could back fire or could go to 2p plus on interims cash balance and newsflow etc